| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/26/2012 | CN102014931B Use and preparation of paeoniflorin and the composition thereof |
| 09/26/2012 | CN102008447B Entecavir solid dispersion and preparation thereof |
| 09/26/2012 | CN101991601B Method for preparing uroacitide composition |
| 09/26/2012 | CN101969935B Thermorod for active drug release and method for manufacturing the same |
| 09/26/2012 | CN101965180B Mixture for producing rapidly disintegrating tablets |
| 09/26/2012 | CN101912357B Gel paste preparation and preparation method thereof |
| 09/26/2012 | CN101822704B Drug combination for removing freckles and preparation method thereof |
| 09/26/2012 | CN101810610B Amoxicillin sodium flucloxacillin sodium medicine compound liposome injection |
| 09/26/2012 | CN101757632B Soft capsule shell composition and application thereof |
| 09/26/2012 | CN101756925B Glipizide long-acting slow-release preparation and preparation method thereof |
| 09/26/2012 | CN101744777B Omeprazole sodium freeze-dried powder injection, as well as preparation method and quality control method thereof |
| 09/26/2012 | CN101732251B Oxiracetam liposome injection |
| 09/26/2012 | CN101711755B Pressure sensitive adhesive matrix device or system for the treatment or prevention of onychomycosis or tinea pedis |
| 09/26/2012 | CN101704766B Preparation method of arginine aspirin and powder-injection of arginine aspirin |
| 09/26/2012 | CN101686942B Method for preparing rapidly disintegrating formulation for oral administration and apparatus for preparing and packing the same |
| 09/26/2012 | CN101658511B Adhesive patch |
| 09/26/2012 | CN101653410B Lacidipine sustained-release preparation and preparation process thereof |
| 09/26/2012 | CN101621999B Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same |
| 09/26/2012 | CN101612173B Glabrous sarcandra herb extract, quality control method for extract preparation and application of thereof |
| 09/26/2012 | CN101590088B 叶黄素油膏生产中用于清除浸出混合液中杂质的技术 Lutein production techniques used to remove leached ointment mixture of impurities |
| 09/26/2012 | CN101534839B Antioxidant for preventing and treating diseases caused by oxidative stress |
| 09/26/2012 | CN101502549B Notoginsen triterpenes capsule as well as preparation method thereof and method for measuring content |
| 09/26/2012 | CN101491501B Preparation method of ambroxol for injection |
| 09/26/2012 | CN101442983B Drug depot implant designs and methods of implantation |
| 09/26/2012 | CN101420943B Chewing composition containing coenzyme q10 |
| 09/26/2012 | CN101406500B Medicament for treating headache and migraine, and preparation method thereof |
| 09/26/2012 | CN101371843B Use of loxapine and amoxapine for the preparation of a medicament for the treatment of pain |
| 09/26/2012 | CN101194898B Adhesive preparation |
| 09/26/2012 | CN101120955B Enteric coated preparation containing glossy ganoderma spore powder active ingredient |
| 09/26/2012 | CN101103983B Medicinal composition stabilized by base reagent containing pitavastatin calcium and preparation technology thereof |
| 09/26/2012 | CN101086007B Manyzoned polypore glycopeptide production method and formulation thereof |
| 09/25/2012 | US8273876 Medicaments containing vardenafil hydrochloride trihydrate |
| 09/25/2012 | US8273798 Tamper resistant lipid-based oral dosage form for opioid agonists |
| 09/25/2012 | US8273795 Oral administering; controlling blood concentration; sustained release; urogenital disorders; blood disorders |
| 09/25/2012 | US8273729 Treatment of irritable bowel syndrome and related bowel disease |
| 09/25/2012 | US8273728 Preformulation for tabletting natural mixtures of conjugated estrogens |
| 09/25/2012 | US8273727 Lipid-analogous phosphoric triesters |
| 09/25/2012 | US8273711 Topical drug delivery using phosphatidylcholine |
| 09/25/2012 | US8273404 Extraction of solvents from drug containing polymer reservoirs |
| 09/25/2012 | US8273390 Methods and compositions for administration of TRPV1 agonists |
| 09/25/2012 | US8273376 Colonic delivery of metallo-dependent enzymes |
| 09/25/2012 | US8273375 Targeted, efficient release; dosing accuracy, well distributed in intestinal lumen; lipophilic matrix providing bioavailability |
| 09/25/2012 | US8273374 Preservation of bioactive materials by spray drying |
| 09/25/2012 | US8273373 Photocrosslinked biodegradable hydrogel |
| 09/25/2012 | US8273372 Extracellular matrix composition |
| 09/25/2012 | US8273371 Crystalline mesoporous oxide based materials useful for the fixation and controlled release of drugs |
| 09/25/2012 | US8273370 Adhesive patch |
| 09/25/2012 | US8273367 In particular to hygienic disposable absorbent articles like sanitary napkins, panty liners, tampons, incontinent pads, diapers, interlabial pads, breast pads, perspiration pads |
| 09/25/2012 | US8273366 Ophthalmic drug delivery system |
| 09/25/2012 | US8273365 Two-piece, internal-channel osmotic delivery system flow modulator |
| 09/25/2012 | US8273363 Cancer cell targeting using nanoparticles |
| 09/25/2012 | US8273362 Cationic ophthalmic oil-in-water type emulsion; colloid particles, oily core surrounded by interfacial film; poloxamers, tyloxapol non ionic surfactant; prostaglandin is latanoprost, unoprostone isopropyl; chitosan, chlorhexidine, benzalkonium halide, vegetable oils; eye drops, ointment, ophthalmic gel |
| 09/25/2012 | US8273359 Therapeutic use of at least one botulinum neurotoxin in the treatment of pain induced by at least one anti-neoplastic agent |
| 09/25/2012 | US8273342 Anti-virus therapy for respiratory diseases |
| 09/25/2012 | US8273331 Combination of medicament and lactose particles; accurate, uniform, consistent dispersion for multidose dry powder inhaler |
| 09/25/2012 | US8273330 Particulate materials |
| 09/25/2012 | US8273324 Embolization |
| 09/25/2012 | US8273075 Osmotic pump with remotely controlled osmotic flow rate |
| 09/25/2012 | CA2585940C Orally dispersible pharmaceutical composition and process for the preparation thereof |
| 09/25/2012 | CA2567400C Solid pharmaceutical formulation |
| 09/25/2012 | CA2558985C Erythropoietin liquid formulation |
| 09/25/2012 | CA2549522C Chewable soft capsules containing ungelatinized starch |
| 09/25/2012 | CA2529984C Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors |
| 09/25/2012 | CA2491524C Vaccine against salmonid rickettsial septicaemia |
| 09/25/2012 | CA2489427C Combination of azelastine and steroids |
| 09/25/2012 | CA2443159C Liquid formulations for dermal application in treatment of parasitic insects in animals |
| 09/25/2012 | CA2389337C Reversibly inactivated acidified plasmin |
| 09/20/2012 | WO2012125996A2 Denture adhesive remover for intraoral and extraoral use |
| 09/20/2012 | WO2012125987A2 Delivery system |
| 09/20/2012 | WO2012125914A1 Injectable delivery system for heparan sulfate binding growth factors |
| 09/20/2012 | WO2012125856A1 Maintaining antibody-binding activity of immunosuppressant drug conjugates |
| 09/20/2012 | WO2012125830A2 Curcumin combination with anti-type 2 diabetic drugs for prevention and treatment of disease sequelae, drug-related adverse reactions, and improved glycemic control |
| 09/20/2012 | WO2012125567A2 Vaccine formulation of mannose coated peptide particles |
| 09/20/2012 | WO2012125552A2 Methods of electric field induced delivery of compounds, compositions used in delivery, and system of delivery |
| 09/20/2012 | WO2012125486A1 Combination chemotherapy for treating cancer |
| 09/20/2012 | WO2012125413A2 Compositions for ameliorating systemic inflammation and methods for making and using them |
| 09/20/2012 | WO2012125408A1 Pegylated apelin and uses thereof |
| 09/20/2012 | WO2012125297A1 Porous disintegratable solid substrate for personal health care applications |
| 09/20/2012 | WO2012125214A1 Topical nitric oxide systems and methods of use thereof |
| 09/20/2012 | WO2012125142A1 Sugar free / non-cariogenic encapsulation matrix |
| 09/20/2012 | WO2012125034A1 Method for treating neurotrauma |
| 09/20/2012 | WO2012125020A1 Method for treating neurotrauma |
| 09/20/2012 | WO2012124982A2 Oral preparation having an enteric coating |
| 09/20/2012 | WO2012124973A2 Combined formulation with improved stability |
| 09/20/2012 | WO2012124966A2 Fentanyl transdermal patch |
| 09/20/2012 | WO2012124869A1 Drug delivery system including laminated structure |
| 09/20/2012 | WO2012124827A1 Binder for tablet forming |
| 09/20/2012 | WO2012124688A1 Vector for pulmonary delivery, inducing agent, and uses |
| 09/20/2012 | WO2012123922A1 Controlled release pharmaceutical compositions of selective serotonin reuptake inhibitor |
| 09/20/2012 | WO2012123720A1 Colonoscopy - preparation |
| 09/20/2012 | WO2012123539A1 Treatment of vaginal atrophy as novel indication for myrrh |
| 09/20/2012 | WO2012123515A1 An ophthalmic composition |
| 09/20/2012 | WO2012123491A1 Use of type a2 proanthocyanidins in gastroprotected form for the treatment of acute cystitis induced by fimbriated bacterial forms e |
| 09/20/2012 | WO2012123466A1 Use of a sprayable composition comprising ambroxol |
| 09/20/2012 | WO2012123435A1 Platinium/silver noble metal single wall hollow nanoparticles and their preparation process |
| 09/20/2012 | WO2012122725A1 Vaccine injection, preparation method and use thereof |
| 09/20/2012 | WO2012122678A1 Uniform freeze-dried preparation containning all components of pilose antler and production method thereof |
| 09/20/2012 | WO2012103186A3 Androgen composition for treating an opthalmic condition |
| 09/20/2012 | WO2012103016A3 Extended-release beta agonist/anticholinergic transdermal patches and methods for using the same |
| 09/20/2012 | WO2012103015A3 Extended-release beta agonist/steroid transdermal patches and methods for using the same |